These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Upstream therapy for atrial fibrillation]. Goette A; Hammwöhner M; Bukowska A Herzschrittmacherther Elektrophysiol; 2014 Mar; 25(1):33-40. PubMed ID: 24519662 [TBL] [Abstract][Full Text] [Related]
8. Atrial fibrillation: from ion channels to bedside treatment options. Singh B J Electrocardiol; 2009; 42(6):660-70. PubMed ID: 19520377 [TBL] [Abstract][Full Text] [Related]
9. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part I: Molecular and ionic fundamentals of antiarrhythmic drug actions. Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M Ital Heart J; 2003 Jul; 4(7):430-41. PubMed ID: 14558293 [TBL] [Abstract][Full Text] [Related]
10. [New class III antiarrhythmic drugs for treatment of atrial fibrillation]. Maĭkov EB Kardiologiia; 2012; 52(11):56-65. PubMed ID: 23237397 [TBL] [Abstract][Full Text] [Related]
11. [Drugs for heart rate control and non-antiarrhythmic drugs in atrial fibrillation]. Chávez LL Arch Cardiol Mex; 2007; 77 Suppl 2():S2-54-S2-58. PubMed ID: 17972380 [TBL] [Abstract][Full Text] [Related]
12. New directions in antiarrhythmic drug therapy for atrial fibrillation. Heijman J; Voigt N; Dobrev D Future Cardiol; 2013 Jan; 9(1):71-88. PubMed ID: 23259476 [TBL] [Abstract][Full Text] [Related]
13. Non-invasive assessment of the effect of beta blockers and calcium channel blockers on the AV node during permanent atrial fibrillation. Sandberg F; Corino VD; Mainardi LT; Ulimoen SR; Enger S; Tveit A; Platonov PG; Sörnmo L J Electrocardiol; 2015; 48(5):861-6. PubMed ID: 26275982 [TBL] [Abstract][Full Text] [Related]
14. Novel K+ Channel Targets in Atrial Fibrillation Drug Development--Where Are We? El-Haou S; Ford JW; Milnes JT J Cardiovasc Pharmacol; 2015 Nov; 66(5):412-31. PubMed ID: 25978691 [TBL] [Abstract][Full Text] [Related]
15. New antiarrhythmic agents for atrial fibrillation and atrial flutter. Pecini R; Elming H; Pedersen OD; Torp-Pedersen C Expert Opin Emerg Drugs; 2005 May; 10(2):311-22. PubMed ID: 15934869 [TBL] [Abstract][Full Text] [Related]
16. New concepts in understanding and modulating atrial repolarisation in patients with atrial fibrillation. Dobrev D J Interv Card Electrophysiol; 2008 Aug; 22(2):107-10. PubMed ID: 18330686 [TBL] [Abstract][Full Text] [Related]
17. Amiodarone and atrial fibrillation. London B J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1321-2. PubMed ID: 17971150 [No Abstract] [Full Text] [Related]
18. Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness. Milberg P; Frommeyer G; Ghezelbash S; Rajamani S; Osada N; Razvan R; Belardinelli L; Breithardt G; Eckardt L Europace; 2013 May; 15(5):761-9. PubMed ID: 23376977 [TBL] [Abstract][Full Text] [Related]
19. Status of Antiarrhythmic Drug Development for Atrial Fibrillation: New Drugs and New Molecular Mechanisms. Hanley CM; Robinson VM; Kowey PR Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e002479. PubMed ID: 26936819 [No Abstract] [Full Text] [Related]